Page 2 - Prnewswire Cytocom Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire cytocom inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Cytocom Inc Today - Breaking & Trending Today

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Russian Federation , Nichol Ochsner , Maureen Mcenroe , Michaelk Handley , Cleveland Biolabs , Imquest Life Sciences , Senior Portfolio Venture Opportunities Fund , Covington Burling , Global Yield , Corporate Communications , European Union , Cytocom Inc , Prnewswire Cytocom Inc , Share Subscription , Avenue Capital , Adit Ventures , Capital Partners , Tchad Norman , Senior Portfolio Manager , Avenue Venture Opportunities , Looking Statements , Annual Report , ஒன்றுபட்டது மாநிலங்களில் , ரஷ்ய கூட்டமைப்பு , நிக்கோல் ஓசஸ்னெர் ,

Cytocom Receives FDA Clearance of IND for Phase 2 Clinical Trial of CYTO-205 as Treatment for COVID-19

Share this article
Share this article
FORT COLLINS, Colo., March 16, 2021 /PRNewswire/ Cytocom, Inc., a leading biopharmaceutical company creating next generation immune therapies, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for a Phase 2 clinical trial to evaluate the safety and efficacy of CYTO-205 as a treatment to slow or halt the progression of SARS-CoV-2, the virus that causes COVID-19. CYTO-205 is designed to modulate immune system function, decrease elevated inflammatory responses associated with viral infection and inhibit viral replication in human lung cells.
The trial, titled,
Even as new vaccines are introduced into the market and inoculation programs continue to expand, the need for safe and effective therapies to treat COVID-19 remains undiminished, especially in light of the spread of new, highly contagious variants of the virus, stated Michael Handley, President ....

Loma Linda , Maureen Mcenroe , Michael Handley , World Health Organization , Drug Administration , Loma Linda University Health In , Cytocom Inc , Prnewswire Cytocom Inc , Investigational New Drug , Evaluate Safety , Adult Patients With Mild , Who Are , High Risk , Disease Progression , Loma Linda University Health , Looking Statements , Miriam Miller , லோமா லிண்டா , மவ்ரீன் அம்கெந்ரொ , மைக்கேல் ஹேண்ட்லி , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , லோமா லிண்டா பல்கலைக்கழகம் ஆரோக்கியம் இல் , ஹூ உள்ளன , உயர் ஆபத்து , நோய் ப்ரோக்ரெஶந் , லோமா லிண்டா பல்கலைக்கழகம் ஆரோக்கியம் ,

Cytocom to Present at BIO CEO & Investor Digital Conference

/PRNewswire/ Cytocom, Inc., a leading biopharmaceutical company creating second generation immune therapies, announced today that Mike Handley, President. ....

Maureen Mcenroe , Mike Handley , Cytocom Inc , Prnewswire Cytocom Inc , Fort Collins , Chief Executive Officer , Digital Conference , Looking Statements , Miriam Miller , மவ்ரீன் அம்கெந்ரொ , மைக் ஹேண்ட்லி , கோட்டை கோலின்ஸ் , தலைமை நிர்வாகி அதிகாரி , டிஜிட்டல் மாநாடு , பார்க்கிறது அறிக்கைகள் , மிரியம் மில்லர் ,

Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"

Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"
baytownsun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baytownsun.com Daily Mail and Mail on Sunday newspapers.

Maureen Mcenroe , Hc Wainwright Bioconnect , Imquest Life Sciences Inc , Contact Tiberend Strategic Advisors Inc , Cleveland Biolabs Inc , Cytocom Inc , Prnewswire Cytocom Inc , Biotech Showcase Digital , Annual Healthcare Conference , Imquest Life Sciences , Cleveland Biolabs , Nasdaq Capital , Looking Statements , Tiberend Strategic Advisors , Miriam Miller , Johanna Bennett , மவ்ரீன் அம்கெந்ரொ , பயோடெக் காட்சி பெட்டி டிஜிட்டல் , ஆண்டு சுகாதாரம் மாநாடு , நாஸ்டாக் மூலதனம் , பார்க்கிறது அறிக்கைகள் , மிரியம் மில்லர் , ஜோஹன்னா பென்னட் ,